Navigation Links
Avanir Pharmaceuticals Reports Fiscal 2012 Third Quarter Financial And Business Results
Date:8/8/2012

M PRODUCT SALESGross product sales

$
2,205,811$
2,187,124$
29,676,740$
2,692,090Less: discounts and allowances

2,155,238254,8894,995,531297,841Net product sales

10,050,5731,932,23524,681,2092,394,249Cost of product sales

563,527119,2081,407,675233,535Product gross margin

9,487,0461,813,02723,273,5342,160,714OTHER REVENUESRevenues from royalties

487,423547,9003,062,0583,340,876Total other revenues

487,423547,9003,062,0583,340,876Total gross margin9,974,4692,360,92726,335,5925,501,590OPERATING EXPENSESResearch and development

6,831,2063,258,95016,970,8769,622,129Selling, general and administrative

17,855,26915,150,05357,091,29238,522,264Total operating expenses

24,686,47518,409,00374,062,16848,144,393Loss from operations(14,712,006)(16,048,076)(47,726,576)(42,642,803)OTHER INCOME (EXPENSE)Interest income

7,89010,84830,06328,031Interest expense

(326,098)(326,098)Other, net

-(28,332)4,081(28,295)Loss before provision for income taxes(15,030,214)(16,065,560)(48,018,530)(42,643,067)Provision for income taxes

----Net loss and comprehensive loss$
(15,030,214)$
(16,065,560)$
(48,018,530)$
(42,643,067)Basic and diluted net loss per share$
(0.11)$
(0.13)$
(0.36)$
(0.36)Basic and diluted weighted average number of common shares outstanding 

135,825,005123,354,986132,391,195117,747,185 

 


'/>"/>
SOURCE Avanir Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Avanir Pharmaceuticals to Participate in Citi 2012 Global Health Care Conference
2. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
3. Convergence Pharmaceuticals Initiates Phase I Multiple Ascending Dose Study for CNV2197944
4. TetraLogic Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of TL32711 in Patients with Acute Myelogenous Leukemia (AML)
5. Questcor Pharmaceuticals to Present at the Oppenheimer Healthcare Conference on December 13, 2011
6. Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior VP of R&D, Dr. Mark G. Currie
7. Acumen Pharmaceuticals Regains Worldwide Rights to Anti-ADDL Antibody Therapeutics and Diagnostics for Alzheimers Disease From Merck
8. Inspiration Biopharmaceuticals Moves Corporate Headquarters to Cambridge, Massachusetts
9. Ampio Pharmaceuticals Awarded Canadian Composition of Matter Patent That Strengthens IP Protection for Its Key Drug Ampion™
10. Amylin Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
11. Inovio Pharmaceuticals Promotes Niranjan Sardesai to Chief Operating Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Can economic incentives such as gift ... of the public to increase their donations of blood? ... Carey Business School Assistant Professor Mario Macis says ... large body of recent research that supports their argument, ... issue of Science that the World Health Organization and ...
(Date:5/23/2013)...  Rahal Letterman Lanigan Racing (RLL) and StemCyte, Inc., ... banking and therapeutics, announced today that StemCyte has become ... Indy car driven by James Jakes ... IndyCar 2013 season.   StemCyte, Inc. and Rahal ... of umbilical cord blood banking and its educational initiative ...
(Date:5/23/2013)... HILLS, Calif. , May 23, 2013  Saddleback ... recently became the first hospital on the ... robotic technology. This new surgical option provides women with ... Marc Winter , M.D., ... gynecologist and surgeon and medical director of minimally invasive ...
(Date:5/23/2013)... , May 23, 2013 Z Trim Holdings, ... ingredients to a variety of industries, announced that Chef ... panel discussion at this year,s National Restaurant Association ("NRA") ... on behalf of the Research Chefs Association.  Chef Ryan ... The Good, the Bad and the Ugly," joining four ...
Breaking Biology Technology:Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 2Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 3StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 2StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 3Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 2Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 3Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 2Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 3
... Oct. 31 ThermoGenesis,Corp. (Nasdaq: KOOL ), a ... stem cells, announced today it will report,financial results for ... November 6, 2008., Company,s Conference Call and Webcast, ... 6, 2008 at,2:00 PM Pacific (5:00 PM Eastern) to ...
... Corp. (OTC,Bulletin Board: SCOM) ("Sharps" or the "Company"), ... quantity generators of medical,waste, today announced the appointment ... Chief Operating Officer, effective October 27,2008. Mr. Grow, ... Board of Directors,since October of 2005, will retain ...
... Oct. 31 LI-COR Biosciences now offers,the LI-COR ... blot washing,and secondary antibody addition for Western blots. ... or multiple blots, the,LI-COR Blot Washer is an ... user-defined, preset wash cycles. Up to 20 presets ...
Cached Biology Technology:ThermoGenesis Corp. to Announce First Quarter Fiscal 2009 Results on November 6, 2008 2Sharps Compliance Corp. Announces Appointment of John R. Grow as President and Chief Operating Officer 2Sharps Compliance Corp. Announces Appointment of John R. Grow as President and Chief Operating Officer 3LI-COR Blot Washer Automates Western Blot Processing 2
(Date:5/24/2013)... studying noise in one French Quarter neighborhood of New ... municipal ordinances, Annette Hurley, PhD, Assistant Professor of Audiology ... Arriaga, a third-year LSUHSC doctor of audiology student, recommend ... hearing health. Their case study is published online in ... Management ., "An important part of an audiologist,s practice ...
(Date:5/23/2013)... , Automated conserved noncoding sequence (CNS) discovery ... grasses , Within the genome of each species, ... little change in position and sequence over millions of ... of these evolutionarily stable sequences, so-called conserved noncoding sequences ... genes or the condensation of chromosomes, but the function ...
(Date:5/23/2013)... per year, carrying more than 284 million tons of cargo, ... dollars in toll fees for the Panama Canal Authority. Each ... of water are used from Gatun Lake, which is also ... in the isthmus. , However, the advent of very ... the ships at sea, has demanded change. The Panama Canal ...
Breaking Biology News(10 mins):Please do try this at home 2Frontiers news briefs: May 23 2Frontiers news briefs: May 23 3Reforestation study shows trade-offs between water, carbon and timber 2Reforestation study shows trade-offs between water, carbon and timber 3
... control everything of importance in biology. The genome rules all ... realizing that among the diverse forms of RNA, a kind ... other and with genes directly to manage the genome from ... by the vast stretches of DNA that do not code ...
... in a gene known as SOS1 account for many ... disorder which occurs in one in 1,000-2,500 live births. ... and learning disabilities, as well as heart problems and ... at Harvard Medical School-Partners Healthcare Center for Genetics ...
... on a person's ability to recover from a heart ... Nuclear Medicine. , "Using positron emission tomography (PET) and ... study the regenerative capacity of the heart's sympathetic nervous ... develop new nerves to replace damaged ones--is slower in ...
Cached Biology News:Peering into the shadow world of RNA 2Peering into the shadow world of RNA 3Study uncovers mutation responsible for Noonan Syndrome 2Diabetes slows nerve recovery after heart transplant 2
... Transcend Non-Radioactive Translation Detection Systems allow ... vitro. Using these systems, biotinylated lysine ... during translation, eliminating the need for ... amino acids. This biotinylated lysine is ...
...
... value of your microarray data using ... support you need from consultation to ... up to date methods. Utilize our ... Expression Profiling Service or from your ...
... the value of your microarray data using ... you need from consultation to extensive data ... methods. Utilize our expertise in combination with ... your own microarray experiments., ,Normalization and basic ...
Biology Products: